These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

711 related items for PubMed ID: 7677965

  • 1. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1993 Jan 14; 328(2):73-80. PubMed ID: 7677965
    [Abstract] [Full Text] [Related]

  • 2. Treatment of sickle cell anemia with hydroxyurea and erythropoietin.
    Goldberg MA, Brugnara C, Dover GJ, Schapira L, Charache S, Bunn HF.
    N Engl J Med; 1990 Aug 09; 323(6):366-72. PubMed ID: 1695325
    [Abstract] [Full Text] [Related]

  • 3. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
    Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1990 Apr 12; 322(15):1037-45. PubMed ID: 1690857
    [Abstract] [Full Text] [Related]

  • 4. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP.
    Semin Oncol; 1992 Jun 12; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [Abstract] [Full Text] [Related]

  • 5. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.
    Blood Cells Mol Dis; 2000 Oct 12; 26(5):453-66. PubMed ID: 11112383
    [Abstract] [Full Text] [Related]

  • 6. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
    Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE, Cai SP, Vichinsky EP, Olivieri NF.
    N Engl J Med; 1993 Jan 14; 328(2):81-6. PubMed ID: 7677966
    [Abstract] [Full Text] [Related]

  • 7. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009 Jan 14; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 8. Hydroxyurea and erythropoietin therapy in sickle cell anemia.
    Goldberg MA, Brugnara C, Dover GJ, Schapira L, Lacroix L, Bunn HF.
    Semin Oncol; 1992 Jun 14; 19(3 Suppl 9):74-81. PubMed ID: 1379376
    [Abstract] [Full Text] [Related]

  • 9. Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate.
    McDonagh KT, Dover GJ, Donahue RE, Nathan DG, Agricola B, Byrne E, Nienhuis AW.
    Exp Hematol; 1992 Nov 14; 20(10):1156-64. PubMed ID: 1385194
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
    Veith R, Galanello R, Papayannopoulou T, Stamatoyannopoulos G.
    N Engl J Med; 1985 Dec 19; 313(25):1571-5. PubMed ID: 2415821
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons.
    Al-Khatti A, Veith RW, Papayannopoulou T, Fritsch EF, Goldwasser E, Stamatoyannopoulos G.
    N Engl J Med; 1987 Aug 13; 317(7):415-20. PubMed ID: 2441258
    [Abstract] [Full Text] [Related]

  • 12. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.
    Sher GD, Ginder GD, Little J, Yang S, Dover GJ, Olivieri NF.
    N Engl J Med; 1995 Jun 15; 332(24):1606-10. PubMed ID: 7753139
    [Abstract] [Full Text] [Related]

  • 13. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA.
    Adv Pediatr; 1996 Jun 15; 43():309-34. PubMed ID: 8794181
    [No Abstract] [Full Text] [Related]

  • 14. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
    Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.
    J Matern Fetal Med; 1999 Jun 15; 8(1):1-7. PubMed ID: 10052837
    [Abstract] [Full Text] [Related]

  • 15. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
    el-Hazmi MA, al-Momen A, Warsy AS, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F.
    Acta Haematol; 1995 Jun 15; 93(2-4):57-61. PubMed ID: 7543719
    [Abstract] [Full Text] [Related]

  • 16. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.
    Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasché C, Lochs H, Raedler A.
    N Engl J Med; 1996 Mar 07; 334(10):619-23. PubMed ID: 8592524
    [Abstract] [Full Text] [Related]

  • 17. Hydroxyurea therapy in thalassemia.
    Loukopoulos D, Voskaridou E, Stamoulakatou A, Papassotiriou Y, Kalotychou V, Loutradi A, Cozma G, Tsiarta H, Pavlides N.
    Ann N Y Acad Sci; 1998 Jun 30; 850():120-8. PubMed ID: 9668534
    [Abstract] [Full Text] [Related]

  • 18. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
    Koc A, Gumruk F, Gurgey A.
    Pediatr Hematol Oncol; 2003 Sep 30; 20(6):429-34. PubMed ID: 14631615
    [Abstract] [Full Text] [Related]

  • 19. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT, Dover GJ, Rodgers GP, Serjeant GR, Antonarakis SE, Anagnou NP, Higgs DR, Weatherall DJ, Schechter AN.
    J Clin Invest; 1985 May 30; 75(5):1632-7. PubMed ID: 2581999
    [Abstract] [Full Text] [Related]

  • 20. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG.
    Trans Assoc Am Physicians; 1984 May 30; 97():268-74. PubMed ID: 6085528
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.